My laboratory focuses on understanding and harnessing innate immune cells—such as natural killer (NK) cells, innate lymphoid cells (ILCs), and macrophages—for cancer immunotherapy. We also develop CAR NK cells, CAR T cells, CAR macrophages, and oncolytic viruses to treat various hematologic malignancies and solid tumors.
CRI Research Focus Area(s): Drug Development & Chemical Biology, Tumor Immunology
Cancer immunotherapy, NK cell biology, CAR NK, CAR T, CAR macrophages, ILCs, iPSC, oncolytic virus